# Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke

> **NCT03296618** · PHASE1 · UNKNOWN · sponsor: **Suzhou Neuralstem Biopharmaceuticals** · enrollment: 18 (estimated)

## Conditions studied

- Ischemic Motor Stroke, Chronic

## Interventions

- **DRUG:** NSI-566

## Key facts

- **NCT ID:** NCT03296618
- **Lead sponsor:** Suzhou Neuralstem Biopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2017-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03296618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03296618, "Intracerebral Transplantation of Neural Stem Cells for the Treatment of Ischemic Stroke". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03296618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*